Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiotaOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study characterized the gut (fecal) and blood microbiota of patients with Alzheimer's disease (AD) and mild cognitive impairment (MCI) compared with normal controls, testing the hypothesis that dysbiosis begins in the MCI predementia stage. The goal was to determine whether microbiota changes could serve as early diagnostic biomarkers before the onset of dementia.
Who was studied?
The study enrolled patients with AD, patients with MCI, and normal controls, with diagnoses based on symptoms and neuroimaging (AD biomarkers were not used). Fecal and blood samples were profiled using 16S rRNA gene sequencing, and a diagnostic model was applied to a set of 30 MCI patients.
What were the most important findings?
Patients with AD and MCI had decreased microbial diversity, and 11 genera in feces and 11 genera in blood differed between AD and controls, while no genus-level differences were detected between AD and MCI. Escherichia was increased at the genus level in both fecal and blood samples from AD and MCI patients, and a fecal diagnostic model using all differing genera correctly identified 93% (28 of 30) of MCI patients.
What are the greatest implications of this study?
The authors conclude that gut microbiota alterations occur before AD onset and are already detectable in MCI, offering potential diagnostic biomarkers for early detection of dementia. Because this is an observational study, the findings represent association rather than causation, and the authors note that diagnoses lacked AD biomarker confirmation and that longitudinal prospective studies are needed to link microbiota changes to dementia progression.